Cytochrome P450 2C8 (CYP2C8)

[Edit]

CPC8; Cytochrome P450,Subfamily IIC(Mephenytoin 4-Hydroxylase)Polypeptide 8; S-mephenytoin 4-hydroxylase

Cytochrome P450 2C8 (CYP2C8)
CYP2C8 is one of the major drug-metabolizing CYP450 isoforms. The induction of CYP2C8 in native porcine coronary artery endothelial cells by beta-naphthoflavone enhances the formation of 11,12-epoxyeicosatrienoic acid, as well as endothelium-derived hyperpolarizing factor-mediated hyperpolarization and relaxation. Transfection of coronary arteries with CYP2C8 antisense oligonucleotides resulted in decreased levels of CYP2C and attenuated the endothelium-derived hyperpolarizing factor-mediated vascular responses. Thus, a CYP-epoxygenase product is an essential component of the endothelium-derived hyperpolarizing factor-mediated relaxation in the porcine coronary artery, and CYP2C8 fulfills the criteria for the coronary endothelium-derived hyperpolarization factor synthase.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Cytochrome P450 2C8 (CYP2C8) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Cytochrome P450 2C8 (CYP2C8) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Cytochrome P450 2C8 (CYP2C8) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Cytochrome P450 2C8 (CYP2C8) CLIA Kit Customized Service Offer
n/a ELISA Kit for Cytochrome P450 2C8 (CYP2C8) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Cytochrome P450 2C8 (CYP2C8) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Cytochrome P450 2C8 (CYP2C8) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Cytochrome P450 2C8 (CYP2C8) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Cytochrome P450 2C8 (CYP2C8) CLIA Kit Customized Service Offer
n/a ELISA Kit for Cytochrome P450 2C8 (CYP2C8) ELISA Kit Customized Service Offer
  1. "Characterization of multiple human cytochrome P-450 1 cDNAs. The chromosomal localization of the gene and evidence for alternate RNA splicing."J. Biol. Chem. 262:16072-16079(1987) [PubMed] [Europe PMC] [Abstract]
  2. "cDNA and amino acid sequences of two members of the human P450IIC gene subfamily."Nucleic Acids Res. 15:10053-10054(1987) [PubMed] [Europe PMC] [Abstract]
  3. "Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily."Biochemistry 30:3247-3255(1991) [PubMed] [Europe PMC] [Abstract]
  4. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  5. "The DNA sequence and comparative analysis of human chromosome 10." Nature 429:375-381(2004) [PubMed] [Europe PMC] [Abstract]
  6. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  7. "Isolation of the human cytochrome P-450 IIC8 gene: multiple glucocorticoid responsive elements in the 5' region."Biochim. Biophys. Acta 1088:433-435(1991) [PubMed] [Europe PMC] [Abstract]
  8. "Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform."Arch. Biochem. Biophys. 322:76-86(1995) [PubMed] [Europe PMC] [Abstract]
  9. "Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 (S)-mephenytoin 4'-hydroxylase."Biochemistry 27:6929-6940(1988) [PubMed] [Europe PMC] [Abstract]
  10. "Cloning, expression and chromosomal localization of a member of the human cytochrome P450IIC gene sub-family."Ann. Hum. Genet. 53:23-31(1989) [PubMed] [Europe PMC] [Abstract]
  11. "Sequence of a human liver cytochrome P-450 cDNA clone."Nucleic Acids Res. 18:5550-5550(1990) [PubMed] [Europe PMC] [Abstract]
  12. "A frameshift variant of CYP2C8 was identified in a patient who suffered from rhabdomyolysis after administration of cerivastatin."J. Hum. Genet. 49:582-585(2004) [PubMed] [Europe PMC] [Abstract]
  13. "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]
  14. "Structure of human microsomal cytochrome P450 2C8. Evidence for a peripheral fatty acid binding site."J. Biol. Chem. 279:9497-9503(2004) [PubMed] [Europe PMC] [Abstract]
  15. "Determinants of cytochrome P450 2C8 substrate binding: structures of complexes with montelukast, troglitazone, felodipine, and 9-cis-retinoic acid."J. Biol. Chem. 283:17227-17237(2008) [PubMed] [Europe PMC] [Abstract]
  16. "Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid."Pharmacogenetics 11:597-607(2001) [PubMed] [Europe PMC] [Abstract]
  17. "CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6alpha-hydroxylase activity in human liver microsomes."Biochem. Pharmacol. 64:1579-1589(2002) [PubMed] [Europe PMC] [Abstract]
  18. "Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population."Pharmacogenomics 5:895-931(2004) [PubMed] [Europe PMC] [Abstract]